SCHEMBL2360282

SCHEMBL2360282

CCc1c(C(=O)O)nn(Cc2cccc(C(=O)N3CCN(C)CC3)c2)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.51
TDO2 P48775 2/20 0.51
FAAH O00519 1/20 0.46
MGLL Q99685 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 3/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
PARP1 P09874 4/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TSHR P16473 2/20 0.44
MAPK1 P28482 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 1/20 0.43
GAA P10253 1/20 0.43
RAB9A P51151 1/20 0.43
CHRM2 P08172 1/20 0.41
CHRM3 P20309 1/20 0.41
PDE3B Q13370 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2360375 0.79 IDO1 (0.54) IDO1TDO2FAAHMGLLSMN1; SMN2
SCHEMBL13438861 0.79 SMN1; SMN2 (0.58) IDO1TDO2FAAHMGLLSMN1; SMN2
SCHEMBL2360281 0.76 IDO1 (0.51) IDO1TDO2FAAHMGLLSMN1; SMN2
SCHEMBL2360376 0.75 IDO1 (0.52) IDO1TDO2FAAHMGLLSMN1; SMN2
SCHEMBL2359577 0.74 IDO1 (0.53) IDO1TDO2FAAHMGLLSMN1; SMN2
SCHEMBL2324066 0.74 NOTUM (0.60) IDO1TDO2FAAHMGLLSMN1; SMN2
SCHEMBL14234095 0.73 ALDH1A1 (0.62) MGLLSMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL2360734 0.73 IDO1 (0.52) IDO1TDO2FAAHMGLLSMN1; SMN2
SCHEMBL2359408 0.72 KMT2A (0.49) IDO1TDO2FAAHMGLLSMN1; SMN2
SCHEMBL13657383 0.72 SMN1; SMN2 (0.56) IDO1TDO2FAAHMGLLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356113-B1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS BAYER IP GMBH (DE) 2015-01-07 EP disclosed
EP-2356113-A1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2011-08-17 EP disclosed
WO-2010054763-A1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-05-20 WO disclosed